Further research has confirmed a strong association between anti-MDA5 positivity and rapidly progressive ILD (RP-ILD), particularly in the context of dermatomyositis, with affected individuals demonstrating markedly poor survival outcomes [40]. The gene discussed is IFIH1; the disease is dermatomyositis.